Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:2195:225-243.
doi: 10.1007/978-1-0716-0860-9_15.

A Circulating MicroRNA Panel for Malignant Germ Cell Tumor Diagnosis and Monitoring

Matthew J Murray  1   2 , Cinzia G Scarpini  3 , Nicholas Coleman  4   5
Affiliations

A Circulating MicroRNA Panel for Malignant Germ Cell Tumor Diagnosis and Monitoring

Matthew J Murray et al. Methods Mol Biol. 2021.

Abstract

Reverse transcription (RT) based quantitative PCR (qPCR) for quantifying microRNAs (miRNAs) in in the circulation presents specific challenges. Here, we describe an optimized research protocol to assess serum sample quality and quantify levels of a panel of four test miRNAs (miR-371a-3p, miR-372-3p, miR-373-3p, and miR-367-3p) that enables highly sensitive and specific malignant germ cell tumor (GCT) diagnosis and monitoring. This protocol utilizes a multiplex RT step using Taqman miRNA stem-loop primers. A multiplexed preamplification stage is then employed to increase the sensitivity of the final quantification step, which is performed using standard singleplex Taqman qPCR methodology.

Keywords: Circulating; Preamplification; RT-qPCR; Serum; microRNA.

PubMed Disclaimer

References

    1. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834–838 - DOI
    1. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513–10518 - DOI
    1. Murray MJ, Watson HL, Ward D, Bailey S, Ferraresso M, Nicholson JC et al (2018) “Future-proofing” blood processing for measurement of circulating miRNAs in samples from biobanks and prospective clinical trials. Cancer Epidemiol Biomark Prev 27(2):208–218 - DOI
    1. Bell E, Watson HL, Bailey S, Murray MJ, Coleman N (2017) A robust protocol to quantify circulating cancer biomarker microRNAs. Methods Mol Biol 1580:265–279 - DOI
    1. Kirschner MB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N, Reid G (2013) The impact of hemolysis on cell-free microRNA biomarkers. Front Genet 4:94 - PubMed - PMC

Publication types

MeSH terms

LinkOut - more resources